Chlamydial Persistence: Beyond the Biphasic Paradigm

Infection and Immunity

Volumn 72, Issue 4, 2004, Pages 1843-1855

  Hogan, Richard J ^a   Mathews, Sarah A ^a   Mukhopadhyay, Sanghamitra ^b   Summersgill, James T ^b   Timms, Peter ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

AMINO ACID DEFICIENCY; BACTERIOPHAGE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PSITTACI; DRUG EXPOSURE; EVIDENCE BASED MEDICINE; IN VITRO STUDY; IN VIVO STUDY; IRON DEFICIENCY; MOLECULAR BIOLOGY; MONOCYTE; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY;

BACTERIAL PROTEINS; CHLAMYDIA; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS;

EID: 1842432037     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.4.1843-1855.2004     Document Type: Short Survey

References (126)

1. Airenne, S., H.-M. Surcel, H. Alakärppä, K. Laitinen, J. Paavonen, P. Saikku, and A. Laurila. 1999. Chlamydia pneumoniae infection in human monocytes. Infect. Immun. 67:1445-1449.
2. Allan, I., and J. H. Pearce. 1983. Amino acid requirements of strains of Chlamydia trachomatis and C. psittaci growing in McCoy cells: relationship with clinical syndrome and host origin. J. Gen. Microbiol. 129:2001-2007.
3. Al-Younes, H. M., T. Rudel, V. Brinkmann, A. J. Szczepek, and T. F. Meyer. 2001. Low iron availability modulates the course of Chlamydia pneumoniae infection. Cell. Microbiol. 3:427-437.
4. Balin, B. J., H. C. Gérard, E. J. Arking, D. M. Appelt, P. J. Branigan, J. T. Abrams, J. A. Whittum-Hudson, and A. P. Hudson. 1998. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. 187:23-42.
5. Bavoil, P. M., R.-c. Hsia, B. Brunham, C. M. Fraser, and T. D. Read. 2000. Chlamydia psittaci GPIC and Chlamydia pneumoniae are infected by virtually identical bacteriophages. Proc. Eur. Soc. Chlamydia Res. 4:23.
6. Beatty, W. L., T. A. Belanger, A. A. Desai, R. P. Morrison, and G. I. Byrne, 1994. Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence. Infect. Immun. 62:3705-3711.
7. Beatty, W. L., G. I. Byrne, and R. P. Morrison. 1993. Morphologic and antigenic characterization of interferon γ-mediated persistent Chlamydia trachomatis infection in vitro. Proc. Natl. Acad. Sci. USA 90:3998-4002.
8. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1994. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect. Immun. 62:4059-4062.
9. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1994. Persistent chlamydiae: from cell culture to a paradigm for chlamydial pathogenesis. Microbiol. Rev. 58:686-699.
10. Beatty, W. L., R. P. Morrison, and G. I. Byrne. 1995. Reactivation of persistent Chlamydia trachomatis infection in cell culture. Infect. Immun. 63:199-205.
11. Bedson, S. P., G. T. Western, and S. L. Simpson. 1930. Observations on the aetiology of psittacosis. Lancet i:235-236.
12. Beem, M. O., and E. M. Saxon. 1977. Respiratory-tract colonization and a distinctive pneumonia syndrome in infants infected with Chlamydia trachomatis. N. Engl. J. Med. 296:306-310.
13. Belland, R. J., D. E. Nelson, D. Virok, D. D. Crane, D. Hogan, D. Sturdevant, W. L. Beatty, and H. D. Caldwell. 2003. Transcriptome analysis of chlamydial growth during IFN-γ-mediated persistence and reactivation. Proc. Natl. Acad. Sci. USA 100:15971-15976.
14. Belland, R. J., G. Zhong, D. D. Crane, D. Hogan, D. Sturdevant, J. Sharma, W. L. Beatty, and H. D. Caldwell. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc. Natl. Acad. Sci. USA 100:8478-8483.
15. Blasi, F., D. Legnani, V. M. Lombardo, G. G. Negretto, E. Magliano, R. Pozzoli, F. Chiodo, A. Fasoli, and L. Allegra. 1993. Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur. Respir. J. 6:19-22.
16. Brown, W. J., and D. D. Rockey. 2000. Identification of an antigen localized to an apparent septum within dividing chlamydiae. Infect. Immun. 68:708-715.
17. Byrne, G. I., and D. A. Krueger. 1983. Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin. Infect. Immun. 42:1152-1158.
18. Byrne, G. I., L. K. Lehmann, and G. J. Landry. 1986. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells. Infect. Immun. 53:347-351.
19. Byrne, G. I., S. P. Ouellette, Z. Wang, J. P. Rao, L. Lu, W. L. Beatty, and A. P. Hudson. 2001. Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells. Infect. Immun. 69:5423-5429.
20. Caldwell, H. D., H. Wood, D. Crane, R. Bailey, R. B. Jones, D. Mabey, I. Maclean, Z. Mohammed, R. Peeling, C. Roshick, J. Schachter, A. W. Solomon, W. E. Stamm, R. J. Suchland, L Taylor, S. K. West, T. C. Quinn, R. J. Belland, and G. McClarty. 2003. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J. Clin. Investig. 111:1757-1769.
21. Carlin, J. M., and J. B. Weller. 1995. Potentiation of interferon-mediated inhibition of Chlamydia infection by interleukin-1 in human macrophage cultures. Infect. Immun. 63:1870-1875.
22. Cates, W., and J. N. Wasserheit. 1991. Genital chlamydial infections: epidemiology and reproductive sequelae. Am. J. Obstet. Gynecol. 164:1771-1781.
23. Cevenini, R., M. Donati, and M. La Placa. 1988. Effects of penicillin on the synthesis of membrane proteins of Chlamydia trachomatis LGV2 serotype. FEMS Microbiol. Lett. 56:41-46.
24. Clark, R. B., P. F. Schatzki, and H. P. Dalton. 1982. Ultrastructural analysis of the effects of erythromycin on the morphology and developmental cycle of Chlamydia trachomatis HAR-13. Arch. Microbiol. 133:278-282.
25. Cockram, F. A., and A. R. B. Jackson. 1981. Keratoconjunctivitis of the koala, Phascolarctos cinereus, caused by Chlamydia psittaci. J. Wildl. Dis. 17:497-504.
26. Coles, A. M., D. J. Reynolds, A. Harper, A. Devitt, and J. H. Pearce. 1993. Low-nutrient induction of abnormal chlamydial development: a novel component of chlamydiaI pathogenesis? FEMS Microbiol. Lett. 106:193-200.
27. Dean, D., P. Roblin, L. Mandel, J. Schachter, and M. Hammerschlag. 1998. Molecular evaluation of serial isolates from patients with persistent Chlamydia pneumoniae infections, p. 219-222. In R. S. Stephens, G. I. Byrne, G. Christiansen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgway, P. Saikku, J. Schacbter, and W. E. Stamm (ed.), Chlamydial infections. Proceedings of the Ninth International Symposium on Human Chlamydial Infections. International Cblamydia Symposium, San Francisco, Calif.
28. Dean, D., R. J. Suchland, and W. E. Stamm. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by ompl genotyping. J. Infect. Dis. 182:909-916.
29. Dessus-Babus, S., C. M. Bébéar, A. Charron, C. Bébéar, and B. de Barbeyrac. 1998. Sequencing of gyrase and topoisomerase IV quinolone-resistance-determining regions of Chlamydia trachomatis and characterization of quinolone-resistant mutants obtained in vitro. Antimicrob. Agents Chemother. 42:2474-2481.
30. Dreses-Werringloer, U., I. Padubrin, B. Jürgens-Saathoff, A. P. Hudson, H. Zeidler, and L. Köhler. 2000. Persistence of Chlamydia trachomatis is induced by ciprofloxacin and ofloxacin in vitro. Antimicrob. Agents Chemother. 44:3288-3297.
31. Everett, K. D. E., R. M. Bush, and A. A. Andersen. 1999. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms. Int. J. Syst. Bacteriol. 49:415-440.
32. Fan, P., F. Dong, Y. Huang, and G. Zhong. 2002. Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors is required for major histocompatibility complex antigen expression. Infect. Immun. 70:345-349.
33. Fehlner-Gardiner, C., C. Roshick, J. H. Carlson, S. Hughes, R. J. Belland, H. D. Caldwell, and G. McClarty. 2002. Molecular basis defining human Chlamydia trachomatis tissue tropism: a possible role for tryptophan synthase. J. Biol. Chem. 277:26893-26903.
34. Fukushi, H., and K. Hirai. 1992. Proposal of Chlamydia pecorum sp. nov. for Chlamydia strains derived from ruminants. Int. J. Syst. Bacteriol. 42:306-308.
35. Gérard, H. C., P. J. Branigan, H. R. Schumacher, and A. P. Hudson. 1998. Synovial Chlamydia trachomatis in patients with reactive arthritis/Reiter's syndrome are viable but show aberrant gene expression. J. Rheumatol. 25:734-742.
36. Gérard, H. C., J. Freise, Z. Wang, G. Roberts, D. Rudy, B. Krauß-Opatz, L. Köhler, H. Zeidler, H. R. Schumacher, J. A. Whittum-Hudson, and A. P. Hudson. 2002. Chlamydia trachomatis genes whose products are related to energy metabolism are expressed differentially in active vs. persistent infection. Microbes Infect. 4:13-22.
37. Gérard, H. C., L. Köhler, P. J. Branigan, H. Zeidler, H. R. Schumacher, and A. P. Hudson. 1998. Viability and gene expression in Chlamydia trachomatis during persistent infection of cultured human monocytes. Med. Microbiol. Immunol. 187:115-120.
38. Gérard, H. C., B. Krauße-Opatz, Z. Wang, D. Rudy, J. P. Rao, H. Zeidler, H. R. Schumacher, J. A. Whittum-Hudson, L. Köhler, and A. P. Hudson. 2001. Expression of Chlamydia trachomatis genes encoding products required for DNA synthesis and cell division during active versus persistent infection. Mol. Microbiol. 41:731-741.
39. Gérard, H. C., J. A. Whittum-Hudson, H. R. Schumacher, and A. P. Hudson. 2004. Differential expression of three Chlamydia trachomatis hsp60-encoding genes in active vs. persistent infections. Microb. Pathog. 36:35-39.
40. Gerbase, A. C., J. T. Rowley, and T. E. Mertens. 1998. Global epidemiology of sexually transmitted diseases. Lancet 351(Suppl. 3):2-4.
41. Gieffers, J., L. Durling, S. P. Ouellette, J. Rupp, M. Maass, G. I. Byrne, H. D. Caldwell, and R. J. Belland. 2003. Genotypic differences in the Chlamydia pneumoniae tyrP locus related to vascular tropism and pathogenicity. J. Infect. Dis. 188:1085-1093.
42. Grayston, J. T., C.-C. Kuo, L. A. Campbell, and S.-P. Wang. 1989. Chlamydia pneumoniae sp. nov. for Chlamydia sp. strain TWAR. Int. J. Syst. Bacteriol. 39:88-90.
43. Hahn, D. L., R. W. Dodge, and R. Golubjatnikov. 1991. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 266:225-230.
44. Hammerschlag, M. R., K. Chirgwin, P. M. Roblin, M. Gelling, W. Dumornay, L. Mandel, P. Smith, and J. Schachter. 1992. Persistent infection with Chlamydia pneumoniae following acute respiratory illness. Clin. Infect. Dis. 14:178-182.
45. Harper, A., C. I. Pogson, M. L. Jones, and J. H. Pearce. 2000. Chlamydial development is adversely affected by minor changes in amino acid supply, blood plasma amino acid levels, and glucose deprivation. Infect. Immun. 68:1457-1464.
46. Heuer, D., V. Brinkmann, T. F. Meyer, and A. J. Szczepek. 2003. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell. Microbiol. 5:315-322.
47. Hogan, R. J., S. A. Mathews, A. Kutlin, M. R. Hammerschlag, and P. Timms. 2003. Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections. Microb. Pathog. 34:11-16.
48. Holland, S. M., A. P. Hudson, L. Bobo, J. A. Whittum-Hudson, R. P. Viscidi, T. C. Quinn, and H. R. Taylor. 1992. Demonstration of chlamydial RNA and DNA during a culture-negative state. Infect, Immun, 60:2040-2047.
49. Hsia, R.-C., H. Ohayon, P. Gounon, A. Dautry-Varsat, and P. M. Bavoil. 2000. Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain Guinea Pig Inclusion Conjunctivitis. Microbes Infect. 2:761-772.
50. Igietseme, J. U., G. A. Ananaba, D. H. Candal, D. Lyn, and C. M. Black. 1998. Immune control of chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that include nitric oxide induction, tryptophan catabolism and iron deprivation. Microbiol. Immunol. 42:617-625.
51. Iliffe-Lee, E. R., and G. McClarty. 2000. Regulation of carbon metabolism in Chlamydia trachomatis. Mol. Microbiol, 38:20-30.
52. Jones, M. L., J. S. H. Gaston, and J. H. Pearce. 2001. Induction of abnormal Chlamydia trachomatis by exposure to interferon-γ or amino acid deprivation and comparative antigenic analysis. Microb. Pathog. 30:299-309.
53. Kahane, S., and M. G. Friedman. 1992. Reversibility of heat shock in Chlamydia trachomatis. FEMS Microbiol. Lett. 97:25-30.
54. Kalman, S., W. Mitchell, R. Marathe, C. Lammel, J. Fan, R. W. Hyman, L. Olinger, J. Grimwood, R. W. Davis, and R. S. Stephens. 1999. Comparative genomes of Chlamydiapneumoniae and C. trachomatis. Nat. Genet, 21:385-389.
55. Karunakaran, K. P., J. F. Blanchard, A. Raudonikiene, C. Shen, A. D. Murdin, and R. C. Brunham. 2002. Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (ΦCpn1). J. Clin. Microbiol. 40:4010-4014.
56. Katz, B. P., D. Fortenberry, and D. Orr. 1998. Factors affecting chlamydial persistence or recurrence one and three months after treatment, p. 35-38. In R. S. Stephens, G. I. Byrne, G. Christiansen, I. N. Clarke, J. T. Grayston, R. G. Rank, G. L. Ridgway, P. Saikku, J. Schachter, and W. E. Stamm (ed.), Chlamydial infections, Proceedings of the Ninth International Symposium on Human Chlamydial Infections. International Chlamydia Symposium, San Francisco, Calif.
57. Kelver, M. E., A. Kaul, B. Nowicki, W. E. Findley, T. W. Hutchens, and M. Nagamani. 1996. Estrogen regulation of lactoferrin expression in human endometrium. Am. J. Reprod. Immunol. 36:243-247.
58. Kinnunen, A., J. Paavonen, and H.-M. Surcel. 2001. Heat shock protein 60 specific T-cell response in chlamydial infections. Scand. J. Immunol. 54:76-81.
59. Koehler, L., E. Netteinbreker, A. P. Hudson, N. Ott, H. C. Gérard, P. J. Branigan, H. R. Schumacher, W. Drommer, and H. Zeidler. 1997. Ultrastructural and molecular analyses of the persistence of Chlamydia trachomatis (serovar K) in human monocytes. Microb. Pathog. 22:133-142.
60. Kramer, M. J., and F. B. Gordon. 1971. Ultrastructural analysis of the effects of penicillin and chlortetracycline on the development of a genital tract Chlamydia. Infect. Immun. 3:333-341.
61. Kuo, C.-C., L. A. Jackson, L. A. Campbell, and J. T. Grayston. 1995. Chlamydia pneumoniae (TWAR). Clin. Microbiol. Rev. 8:451-461.
62. Kuo, C.-C., A. Shor, L. A. Campbell, H. Fukushi, D. L. Patton, and J. T. Grayston. 1993. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. J. Infect. Dis. 167:841-849.
63. Kutlin, A., C. Flegg, D. Stenzel, T. Reznik, P. M. Roblin, S. Mathews, P. Timms, and M. R. Hammerschlag. 2001. Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model. J. Clin. Microbiol. 39:3721-3723.
64. Kutlin, A., P. M. Roblin, and M. R. Hammerschlag. 1999. In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. Antimicrob. Agents Chemother. 43:2268-2272.
65. Lee, C. K. 1981. Factors affecting the rate at which a trachoma strain of Chlamydia trachomatis establishes persistent infections in mouse fibroblasts (McCoy cells). Infect. Immun. 33:954-957.
66. Lenart, J., A. A. Andersen, and D. D. Rockey. 2001. Growth and development of tetracycline-resistant Chlamydia suis. Antimicrob. Agents Chemother. 45:2198-2203.
67. Malinverni, R., C.-C. Kuo, L. A. Campbell, and J. T. Grayston. 1995. Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J. Infect. Dis. 172:593-594.
68. Mathews, S., C. George, C. Flegg, D. Stenzel, and P. Timms. 2001. Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and intefferon-γ treated cultures of Chlamydia pneumoniae. Microb. Pathog. 30:337-345.
69. Matsumoto, A., and G. P. Manire. 1970. Electron microscopic observations on the effects of penicillin on the morphology of Chlamydia psittaci. J. Bacteriol. 101:278-285.
70. Mazzoli, S., D. Bani, A. Salvi, I. Ramacciotti, C. Romeo, and T. Bani. 2000. In vivo evidence of Chlamydia trachomatis miniature reticulary bodies (MRB) as persistence markers in patients with chronic chlamydial prostatitis, Proc. Eur. Soc. Chlamydia Res. 4:40.
71. McColl, K. A., R. W. Martin, L. J. Gleeson, K. A. Handasyde, and A. K. Lee. 1984. Chlamydia infection and infertility in the female koala (Phascolarctos cinereus). Vet. Rec. 115:655.
72. Mehta, S. J., R. D. Miller, J. A. Ramirez, and J. T. Summersgill. 1998. Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-γ: role of tryptophan catabolism. J. Infect. Dis. 177:1326-1331.
73. Meyer, K. F., and B. Eddie. 1933. Latent psittacosis infections in shell parakeets. Proc. Soc. Exp. Biol. Med. 30:484-488.
74. Moazed, T. C., C.-C. Kuo, J. T. Grayston, and L. A. Campbell. 1998. Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse. J. Infect. Dis. 177:1322-1325.
75. Molestina, R. E., J. B. Klein, R. D. Miller, W. H. Pierce, J. A. Ramirez, and J. T. Summersgill. 2002. Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells. Infect. Immun. 70:2976-2981.
76. Morrison, R. P. 2000. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon. Infect. Immun. 68:6038-6040.
77. Morrison, R. P., R. J. Belland, K. Lyng, and H. D. Caldwell. 1989. Chlamydial disease pathogenesis: the 57-kD chlamydial hypersensitivity antigen is a stress response protein. J. Exp. Med. 170:1271-1283.
78. Moulder, J. W. 1991. Interaction of chlamydiae and host cells in vitro. Microbiol. Rev. 55:143-190.
79. Moulder, J. W. 1966. The relation of the psittacosis group (chlamydiae) to bacteria and viruses. Annu. Rev. Microbiol. 20:107-130.
80. Moulder, J. W., N. J. Levy, and L. P. Schulman. 1980. Persistent infection of mouse fibroblasts (L cells) with Chlamydia psittaci: evidence for a cryptic chlamydial form. Infect. Immun. 30:874-883.
81. Nanagara, R., F. Li, A. Beutler, A. Hudson, and H. R. Schumacher. 1995. Alteration of Chlamydia trachomatis biologic behavior in synovial membranes: suppression of surface antigen production in reactive arthritis and Reiter's syndrome. Arthritis Rheum. 38:1410-1417.
82. Nicholson, T., and R. S. Stephens. 2002. Chlamydial genomic transcriptional profile for penicillin-induced persistence, p. 611-614, In J. Schachter, G. Christiansen, I. N. Clarke, M. R. Hammerschlag, B. Kaltenboeck, C.-C. Kuo, R. G. Rank, G. L. Ridgway, P. Saikku, W. E. Stamm, R. S. Stephens, J. T. Summersgill, P. Timms, and P. B. Wyrick (ed.), Chlamydial infections. Proceedings of the Tenth International Symposium on Human Chlamydial Infections. International Chlamydia Symposium, San Francisco, Calif.
83. Nicholson, T. L., L. Olinger, K. Chong, G. Schoolnik, and R. S. Stephens. 2003. Global stage-specific gene regulation during the developmental cycle of Chlamydia trachomatis. J. Bacteriol. 185:3179-3189.
84. Officer, J. E., and A. Brown. 1961. Serial changes in virus and cells in cultures chronically infected with psittacosis virus. Virology 14:88-99.
85. Page, L. A. 1968. Proposal for the recognition of two species in the genus Chlamydia Jones, Rake, and Stearns, 1945. Int. J. Syst. Bacteriol. 18:51-66.
86. Page, L. A. 1966. Revision of the family Chlamydiaceae Rake (Rickettsiales): unification of the psittacosis-lymphogranuloma venereum-trachoma group of organisms in the genus Chlamydia Jones, Rake and Stearns, 1945. Int. J. Syst. Bacteriol. 16:223-252.
87. Pantoja, L. G., R. D. Miller, J. A. Ramirez, R. E. Molestina, and J. T. Summersgill. 2001. Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon. Infect. Immun. 69:7927-7932.
88. Pantoja, L. G., R. D. Miller, J. A. Ramirez, R. E. Molestina, and J. T. Summersgill. 2000. Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2,3-dioxygenase activity. Infect. Immun. 68:6478-6481.
89. Papp, J. R., and P. E. Shewen. 1996. Localization of chronic Chlamydia psittaci infection in the reproductive tract of sheep. J. Infect. Dis. 174:1296-1302.
90. Patnode, D., S.-P. Wang, and J. T. Grayston. 1990. Persistence of Chlamydia pneumoniae, strain TWAR, microimmunofluorescent antibody, p. 406-409. In W. R. Bowie, H. D. Caldwell, R. P. Jones, P.-A. Mårdh, G. L. Ridgway, J. Schachter, W. E. Stamm, and M. E. Ward (ed.), Chlamydial infections. Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Cambridge University Press, Cambridge, United Kingdom.
91. Patton, D. L., M. Askienazy-Elbhar, J. Henry-Suchet, L. A. Campbell, A. Cappuccio, W. Tannous, S.-P. Wang, and C.-C. Kuo. 1994. Detection of Chlamydia trachomatis in fallopian tube tissue in women with postinfectious tubal infertility. Am. J. Obstet. Gynecol. 171:95-101.
92. Phillips, D. M., C. E. Swenson, and J. Schachter. 1984. Ultrastructure of Chlamydia trachomatis infection of the mouse oviduct. J. Ultrastruct. Res. 88:244-256.
93. Rahman, M. U., M. A. Cheema, H. R. Schumacher, and A. P. Hudson. 1992. Molecular evidence for the presence of chlamydia in the synovium of patients with Reiter's syndrome. Arthritis Rheum. 35:521-529.
94. Ramsey, K. H., G. S. Miranpuri, I. M. Sigar, S. Ouellette, and G. I. Byrne. 2001. Chlamydia trachomatis persistence in the female mouse genital tract: inducible nitric oxide synthase and infection outcome. Infect. Immun. 69:5131-5137.
95. Raulston, J. E. 1997. Response of Chlamydia trachomatis serovar E to iron restriction in vitro and evidence for iron-regulated chlamydial proteins. Infect. Immun. 65:4539-4547.
96. Read, T. D., R. C. Brunham, C. Shen, S. R. Gill, J. F. Heidelberg, O. White, E. K. Hickey, J. Peterson, T. Utterback, K. Berry, S. Bass, K. Linher, J. Weidman, H. Khouri, B. Craven, C. Bowman, R. Dodson, M. Gwinn, W. Nelson, R. DeBoy, J. Kolonay, G. McClarty, S. L. Salzberg, J. Eisen, and C. M. Fraser. 2000. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res. 28:1397-1406.
97. Read, T. D., G. S. A. Myers, R. C. Brunham, W. C. Nelson, I. T. Paulsen, J. Heideiberg, E. Holtzapple, H. Khouri, N. B. Federova, H. A. Carty, L. A. Umayam, D. H. Haft, J. Peterson, M. J. Beanan, O. White, S. L. Salzberg, R.-C. Hsia, G. McClarty, R. G. Rank, P. M. Bavoil, and C. M. Fraser. 2003. Genome sequence of Chlamydophila caviae (Chlamydia psittaci GPIC): examining the role of niche-specific genes in the evolution of the Chlamy-diaceae. Nucleic Acids Res. 31:2134-2147.
98. Richmond, S. J., P. Stirling, and C. R. Ashley. 1982. Virus infecting the reticulate bodies of an avian strain of Chlamydia psittaci. FEMS Microbiol. Lett. 14:31-36.
99. Ridgway, G. L. 2002. Antibiotic resistance in human chlamydial infection: should we be concerned?, p. 343-352. In J. Schachter, G. Christiansen, I. N. Clarke, M. R. Hammerschlag, B. Kaltenboeck, C.-C. Kuo, R. G. Rank, G, L. Ridgway, P. Saikku, W. E. Stamm, R. S. Stephens, J. T. Summersgill, P, Timms, and P. B. Wyrick (ed.), Chlamydial infections. Proceedings of the Tenth International Symposium on Human Chlamydial Infections, International Chlamydia Symposium, San Francisco, Calif.
100. Rothermel, C. D., B. Y. Rubin, E. A. Jaffe, and H. W. Murray. 1986. Oxygen-independent inhibition of intracellular Chlamydia psittaci growth by human monocytes and interferon-γ-activated macrophages. J. Immunol. 137:689-692.
101. Rothermel, C. D., B. Y. Rubin, and H. W. Murray. 1983. γ-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication. J. Immunol. 131:2542-2544.
102. Saikku, P., M. Leinonen, K. Mattila, M.-R. Ekman, M. S. Nieminen, P. H. Mäkelä, J. K. Huttunen, and V. Valtonen. 1988. Serological evidence of an association of a novel chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction, Lancet ii:983-986.
103. Sakasb, J. B., G. I. Byrne, A. Lichtman, and P. Libby. 2002, Cytokines induce indoleamine 2,3-dioxygenase expression in human atheroma-associated cells: implications for persistent Chlamydophila pneumoniae infection. Infect. Immun. 70:3959-3961.
104. Sardinia, L. M., E. Segal, and D. Ganem. 1988. Developmental regulation of the cysteine-rich outer-membrane proteins of murine Chlamydia trachomatis. J. Gen. Microbiol. 134:997-1004.
105. Schachter, J., M. Grossman, R. L. Sweet, J. Holt, C. Jordan, and E. Bishop. 1986. Prospective study of perinatal transmission of Chlamydia trachomatis. JAMA 255:3374-3377.
106. Schachter, J., R. S. Stephens, P. Timms, C. Kuo, P. M. Bavoil, S. Birkelund, J. Boman, H. Caldwell, L. A. Campbell, M. Chernesky, G. Christiansen, I. N. Clarke, C. Gaydos, J. T. Grayston, T. Hackstadt, R. Hsia, B. Kaltenboeck, M. Leinonnen, D. Ojcius, G. McClarty, J. Orfila, R. Peeling, M. Puolakkainen, T. C. Quinn, R. G. Rank, J. Raulston, G. L. Ridgway, P. Saikku, W. E. Stamm, D. Taylor-Robinson, S.-P. Wang, and P. B. Wyrick. 2001. Radical changes to chlamydial taxonomy are not necessary just yet. Int. J. Syst. Evol. Microbiol. 51:249, 251-253.
107. Shatkin, A. A., O. E. Orlova, V. L. Popov, S. R. Beskina, V. N. Pankratova, I. F. Rogacheva, S. I. Soldatova, N. S. Smirnova, and N. I. Shcherbakova. 1985. Persistentnaia khlamidiinaia infektsiia v kul'ture kletok. Vestn. Akad. Med. Nauk SSSR 3:51-55.
108. Shaw, A. C., G. Christiansen, and S. Birkelund. 1999. Effects of interferon gamma on Chlamydia trachomatis serovar A and L2 protein expression investigated by two-dimensional gel electrophoresis. Electrophoresis 20:775-780.
109. Shaw, A. C., G. Christiansen, P. Roepstorff, and S. Birkelund. 2000. Genetic differences in the Chlamydia trachomatis tryptophan synthase α-sub-unit can explain variations in serovar pathogenesis. Microbes Infect. 2:581-592.
110. Shaw, A. C., B. B. Vandahl, M. R. Larsen, P. Roepstorff, K. Gevaert, J. Vandekerckhove, G. Christiansen, and S. Birkelund. 2002. Characterization of a secreted Chlamydia protease. Cell. Microbiol. 4:411-424.
111. Shemer, Y., and I. Sarov. 1985. Inhibition of growth of Chlamydia trachomatis by human gamma interferon. Infect. Immun. 48:592-596.
112. Shemer-Avni, Y., D. Wallach, and I. Sarov. 1988. Inhibition of Chlamydia trachomatis growth by recombinant tumor necrosis factor. Infect. Immun. 56:2503-2506.
113. Skowasch, D., K. Yeghiazaryan, S. Schrempf, O. Golubnitschaja, U. Welsch, C. J. Preusse, J. A. Likungu, A. Welz, B. Lüderitz, and G. Bauriedel. 2003. Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homologues. J. Heart Valve Dis. 12:68-75.
114. Siepenkin, A., V. Motin, L. M. de la Maza, and E. M. Peterson. 2003. Temporal expression of type III secretion genes of Chlamydia pneumoniae. Infect. Immun. 71:2555-2562.
115. Somani, J., V. B. Bhullar, K. A. Workowski, C. E. Farshy, and C. M. Black. 2000. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J. Infect. Dis. 181:1421-1427.
116. Stephens, R. S., S. Kalman, C. Lammel, J. Fan, R. Marathe, L. Aravind, W. Mitchell, L. Olinger, R. L. Tatusov, Q. Zhao, E. V. Koonin, and R. W. Davis. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759.
117. Storz, J., J. L. Shupe, L. F. James, and R. A. Smart. 1963. Polyarthritis of sheep in the intermountain region caused by a psittacosis-lymphogranuloma agent. Am. J. Vet. Res. 24:1201-1206.
118. Summersgill, J. T., N. N. Sahney, C. A. Gaydos, T. C. Quinn, and J. A. Ramirez. 1995. Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha. Infect. Immun. 63:2801-2803.
119. Thygeson, P. 1963. Epidemiologic observations on trachoma in the United States. Investig. Ophthalmol. 2:482-489.
120. Wang, S.-P., and J. T. Grayston. 1990. Population prevalence of antibody to Chlamydia pneumoniae, strain TWAR, p. 402-405. In W. R, Bowie, H. D, Caldwell, R. P. Jones, P.-A, Märdh, G, L. Ridgway, J. Schachter, W. E. Stamm, and M. E. Ward (ed.), Chlamydial infections. Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Cambridge University Press, Cambridge, United Kingdom.
121. Whitcber, J. P., M. Srinivasan, and M. P. Upadhyay. 2001. Corneal blindness: a global perspective, Bull, W. H. O. 79:214-221.
122. Wolf, K., E. Fischer, and T. Hackstadt. 2000, Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells, Infect. Immun. 68:2379-2385.
123. Wollenhaupt, J., and H. Zeidler. 1990. Chlamydia-induced arthritis. EULAR Bull. 3:72-77.
124. Wood, H., C. Fehiner-Gardner, J. Berry, E. Fischer, B. Graham, T. Hackstadt, C. Roshick, and G. McClarty. 2003. Regulation of tryptophan synthase gene expression in Chlamydia trachomatis. Mol. Microbiol. 49:1347-1359.
125. Yang, Y.-S., C.-C. Kuo, and W.-J. Chen. 1983. Reactivation of Chlamydia trachomatis lung infection in mice by cortisone. Infect. Immun. 39:655-658.
126. Zhong, G., P. Fan, H. Ji, F. Dong, and Y. Huang. 2001. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors. J. Exp. Med. 193:935-942.